Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Aethlon Medical ( (AEMD) ).
On February 19, 2026, Aethlon Medical held its annual meeting virtually, with a quorum of approximately 57% of its 973,213 outstanding common shares represented. Shareholders elected five directors, ratified Haskell & White LLP as independent auditor for the fiscal year ending March 31, 2026, and approved amendments to the company’s 2020 equity plan.
Investors also approved a major increase in authorized common shares from 6 million to 100 million, significantly expanding Aethlon’s capacity to issue equity. In separate votes tied to Nasdaq Listing Rule 5635(d), shareholders authorized the issuance of up to roughly 2 million shares upon exercise of various warrants related to December 5, 2025 financing agreements, reinforcing the company’s flexibility to raise capital despite potential dilution concerns.
The most recent analyst rating on (AEMD) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Aethlon Medical stock, see the AEMD Stock Forecast page.
Spark’s Take on AEMD Stock
According to Spark, TipRanks’ AI Analyst, AEMD is a Neutral.
The score is held down primarily by very weak financial performance (persistent losses, minimal/zero recent revenue, and sustained cash burn) and bearish technicals (below key moving averages with negative MACD). Offsetting these, the latest earnings call points to meaningful clinical progress and cost reduction, but near-term cash constraints and program timing uncertainty keep risk elevated; valuation metrics add limited support due to loss-making status and no dividend yield provided.
To see Spark’s full report on AEMD stock, click here.
More about Aethlon Medical
Aethlon Medical operates in the healthcare sector and is focused on developing therapeutic devices and related technologies, with its equity listed on Nasdaq. The company’s capital structure centers on common stock, and it actively uses equity-based plans and warrant structures as part of its financing and compensation strategy.
Average Trading Volume: 125,410
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.75M
See more insights into AEMD stock on TipRanks’ Stock Analysis page.